Inventor · disambiguated record
Xiao Xu
Also filed as: XU XIAO · XU XIAO-LI
28 granted patents·10 pending applications·85 citations·filing 2005–2024
95Inventor score
Top patents by PatentIndex Score
38 records- 0193US9464089B2Heterocyclic compounds and uses thereofACEA BIOSCIENCES INC·Filed 2014·Granted Oct 11, 2016·12 cites·19 claims
- 0291US9920074B2Heterocyclic compounds and uses thereofACEA BIOSCIENCES INC·Filed 2016·Granted Mar 20, 2018·6 cites·21 claims
- 0390US10596174B2Pyrrolopyrimidine compounds as inhibitors of protein kinasesACEA BIOSCIENCES INC·Filed 2017·Granted Mar 24, 2020·4 cites·7 claims
- 0490US9763949B2EGFR modulators and uses thereofACEA BIOSCIENCES INC·Filed 2015·Granted Sep 19, 2017·8 cites·32 claims
- 0589US9034885B2EGFR modulators and uses thereofACEA BIOSCIENCES INC·Filed 2013·Granted May 19, 2015·11 cites·23 claims
- 0688US11007197B2EGFR modulators and uses thereofACEA THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·18 claims
- 0784US10449196B2EGFR modulators and uses thereofACEA BIOSCIENCES INC·Filed 2017·Granted Oct 22, 2019·3 cites·19 claims
- 0884US9586965B2Pyrrolo[2,3-d]pyrimidine compounds as inhibitors of protein kinasesACEA BIOSCIENCES INC·Filed 2013·Granted Mar 7, 2017·8 cites·30 claims
- 0983US9806911B2Distributed virtual gateway applianceIBM·Filed 2015·Granted Oct 31, 2017·4 cites·20 claims
- 1081US8383110B2Modulators of Candida hyphal morphogenesis and uses thereofAGENCY SCIENCE TECH & RES·Filed 2007·Granted Feb 26, 2013·3 cites·16 claims
- 1180US10562918B2Heterocyclic compounds and uses thereofACEA BIOSCIENCES INC·Filed 2018·Granted Feb 18, 2020·3 cites·14 claims
- 1277US10277423B2Distributed virtual gateway applianceIBM·Filed 2017·Granted Apr 30, 2019·2 cites·20 claims
- 1376US10533011B2Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making sameACEA THERAPEUTICS INC·Filed 2016·Granted Jan 14, 2020·4 cites·25 claims
- 1475US11987554B2Protease inhibitors as antiviralsACEA THERAPEUTICS INC·Filed 2023·Granted May 21, 2024·0 cites·16 claims
- 1575US10799504B2Heterocyclic compounds and uses as anticancer agentsACEA BIOSCIENCES INC·Filed 2013·Granted Oct 13, 2020·2 cites·8 claims
- 1674US2025122153A1Protease Inhibitors as AntiviralsACEA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1773US8889134B2Modulators of Candida hyphal morphogenesis and uses thereofAGENCY SCIENCE TECH & RES·Filed 2013·Granted Nov 18, 2014·1 cites·6 claims
- 1872US7622507B2Substituted organosulfur compounds and methods of using thereofACEA BIOSCIENCES INC·Filed 2005·Granted Nov 24, 2009·1 cites·29 claims
- 1971US11753373B2Protease inhibitors as antiviralsACEA THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·0 cites·18 claims
- 2071US2015098951A1Modulators of candida hyphal morphogenesis and uses thereofAGENCY SCIENCE TECH & RES·Filed 2014·Application pending·0 cites
- 2171US2015098962A1Modulators of candida hyphal morphogenesis and uses thereofAGENCY SCIENCE TECH & RES·Filed 2014·Application pending·0 cites
- 2270US9819758B2Remote debugging into mobile web applications across devicesSAP SE·Filed 2014·Granted Nov 14, 2017·4 cites·18 claims
- 2369US9684886B2Cross-domain business mashup integrationCUI WEIYI·Filed 2012·Granted Jun 20, 2017·2 cites·16 claims
- 2467US11612602B2Heterocyclic compounds and uses as anticancer agentsACEA THERAPEUTICS INC·Filed 2020·Granted Mar 28, 2023·0 cites·20 claims
- 2566US9107905B2Modulators of Candida hyphal morphogenesis and uses thereofAGENCY SCIENCE TECH & RES·Filed 2013·Granted Aug 18, 2015·0 cites·4 claims
- 2664US11128494B2Distributed virtual gateway applianceIBM·Filed 2020·Granted Sep 21, 2021·0 cites·20 claims
- 2762US9584619B2Business web applications lifecycle management with multi-tasking abilityTANG SIMON·Filed 2014·Granted Feb 28, 2017·3 cites·18 claims
- 2859US10686627B2Distributed virtual gateway applianceIBM·Filed 2019·Granted Jun 16, 2020·0 cites·20 claims
- 2959US9384284B2Value-added usage of process-oriented extension fields in business mashupsSAP AG·Filed 2012·Granted Jul 5, 2016·1 cites·19 claims
- 3056US2025136576A1Heterocyclic Compounds and Uses ThereofACEA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3153US2024010697A1Modified interleukin 2 (il-2) polypeptides, and methods of making and using the sameCYTIMM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3251US10810362B2Page-based incident correlation for network applicationsSAP SE·Filed 2015·Granted Oct 20, 2020·1 cites·16 claims
- 3348US2022289806A1Modified Interleukin 2 (IL-2) Polypeptides, Conjugates and Uses ThereofCYTIMM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3441US11498922B2Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamideACEA THERAPEUTICS INC·Filed 2017·Granted Nov 15, 2022·0 cites·16 claims
- 3541US2012030592A1Mashup Component Authoring Tool For Business Enterprise User InterfacesCUI WEIYI·Filed 2010·Application pending·0 cites
- 3636US2011207751A1Heterocyclic compounds and uses as anticancer agentsMAO LONG·Filed 2011·Application pending·0 cites
- 3735US2014095974A1Secure html javascript code snippet usage in application integrationCUI WEIYI·Filed 2012·Application pending·0 cites
- 3832US2012030581A1Mashup Component Framework for Business Enterprise User InterfacesCUI WEIYI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiao Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →